These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21463285)

  • 1. The pharmacologic treatment of Dravet syndrome.
    Chiron C; Dulac O
    Epilepsia; 2011 Apr; 52 Suppl 2():72-5. PubMed ID: 21463285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapeutic procedures in Dravet syndrome.
    Chiron C
    Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
    Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
    Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
    Inoue Y; Ohtsuka Y;
    Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stiripentol: A Review in Dravet Syndrome.
    Frampton JE
    Drugs; 2019 Nov; 79(16):1785-1796. PubMed ID: 31617141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for Dravet Syndrome.
    Wallace A; Wirrell E; Kenney-Jung DL
    Paediatr Drugs; 2016 Jun; 18(3):197-208. PubMed ID: 26966048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
    Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
    Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
    Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Dravet Syndrome.
    Wirrell EC
    Can J Neurol Sci; 2016 Jun; 43 Suppl 3():S13-8. PubMed ID: 27264138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study.
    Nabbout R; Copioli C; Chipaux M; Chemaly N; Desguerre I; Dulac O; Chiron C
    Epilepsia; 2011 Jul; 52(7):e54-7. PubMed ID: 21569025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate in the treatment of highly refractory patients with Dravet syndrome.
    Kröll-Seger J; Portilla P; Dulac O; Chiron C
    Neuropediatrics; 2006 Dec; 37(6):325-9. PubMed ID: 17357033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
    Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
    Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ketogenic diet in Dravet syndrome.
    Laux L; Blackford R
    J Child Neurol; 2013 Aug; 28(8):1041-4. PubMed ID: 23653425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol for the treatment of seizures associated with Dravet syndrome.
    Chiron C
    Expert Rev Neurother; 2019 Apr; 19(4):301-310. PubMed ID: 30900478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
    Buck ML; Goodkin HP
    Ann Pharmacother; 2019 Nov; 53(11):1136-1144. PubMed ID: 31167540
    [No Abstract]   [Full Text] [Related]  

  • 18. Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).
    Plosker GL
    CNS Drugs; 2012 Nov; 26(11):993-1001. PubMed ID: 23018548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stiripentol (Diacomit) for Dravet syndrome.
    Med Lett Drugs Ther; 2021 Mar; 63(1620):e48-e50. PubMed ID: 33976090
    [No Abstract]   [Full Text] [Related]  

  • 20. Dravet syndrome: Treatment options and management of prolonged seizures.
    Cross JH; Caraballo RH; Nabbout R; Vigevano F; Guerrini R; Lagae L
    Epilepsia; 2019 Dec; 60 Suppl 3():S39-S48. PubMed ID: 31904119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.